Actos (pioglitazone) was approved in July 15, 1999 and it has been in use since then. It is widely prescribed by doctors for the treatment of Type II Diabetes. FDA reports that from January 2010 through October 2010, around 2.3 million patients filled a prescription for a pioglitazone-containing product (including Actos) from outpatient retail pharmacies. Prescription is limited to only those patients whose blood sugar levels cannot be controlled by regulating their exercise and diet. In a report published the American Diabetes Association, adverse drug reports filed with the FDA were reviewed and researchers reportedly found that bladder cancer is associated with pioglitazone use.
Approximately 563,640 people are afflicted with bladder cancer in the U.S. today. Just in 2013, 72,570 new cases of bladder cancer developed across the country's population. The disease usually starts in the transitional cells or the cells lining the bladder, and causes symptoms such as blood in urine, fatigue, abdominal pain, weight loss and urinary urgency. Similar symptoms can be caused by other conditions as well, so your doctor will make use of physical examinations and diagnostic tests to rule out other possible causes. Diagnosis is done by making use of abdominal CT scan, bladder biopsy, Cystoscopy, urinalysis, urine cytology and/or abdominal MRI scan.
The Link between Bladder Cancer and ActosIn preclinical carcinogenicity studies of Actos (pioglitazone), it was observed that male rats receiving doses of pioglitazone developed bladder tumors. These doses resulted in blood drug levels that were equivalent to those produced from a clinical dose. The results obtained from two, three-year controlled clinical studies of Actos demonstrated that a higher percentage of bladder cancer cases occur in patients using Actos.
In 2011, the U.S. Food and Drug Administration (FDA) issued a Safety Announcement informing the public that the use of Actos for more than twelve months may be associated with an increased risk of bladder cancer. FDA is currently conducting a ten-year epidemiological study and this safety information is based on the interim data analysis of this study.
Actos LawsuitsLawsuits filed against Takeda Pharmaceuticals claim that the drug manufacturers knowingly concealed research data from the general public, especially regarding the link between Actos usage and bladder cancer. Instead of providing a clear-cut picture, they released limited data to the regulators and a misleading perception was created in the minds of the consumers through various marketing campaigns. More than 3,000 lawsuits brought against Takeda in 2013 contented that the company gave more preference to protect annual Actos sales of more than $1.6 billion rather than the lives of its consumers.
Managing your ConditionAlthough bladder cancer can be treated if detected early, it has a high recurrence rate. The financial, physical and emotional turmoil resulting from bladder cancer can be quiet costly. You are likely to incur loss of income because of your inability to work and because of the increased medical bills for checkups, medications, surgery, and care-giving, not to mention the potential for decreased life expectancy. An Actos bladder cancer attorney will help you file a lawsuit against drug manufacturers to acquire compensation against these factors.
Please request for more information relevant to your case by filling out the form above.Q:What does FDA say about bladder cancer from Asbestos?
A:In 2011, the U.S. Food and Drug Administration (FDA) issued a warning to let people know that Actos can be dangerous, if used for more than twelve months. According to FDA, if the use of Actos exceeds a year, it can increase the chances of having bladder cancer. Safety information by FDA is based on its interim data of a ten year study.
Q:How much compensation can I claim for Actos bladder cancer symptoms?
A:There is not a specific number for compensation received by individuals who have suffered from Actos bladder cancer symptoms. If you want to have an estimate of the amount of compensation you can receive for the suffering and harmful effects of Actos, you will need to contact a lawyer who is an expert in Actos cases.
Q:Can you tell me if diabetic people can have Actos bladder cancer risk?
A:Actos is a drug which is widely prescribed for the treatment of type 2 diabetes. In 2011, the U.S. Food and Drug Administration (FDA) warned the public with a safety announcement that the use of Actos for more than twelve months can lead to bladder cancer. FDA is also conducting a ten year epidemiological study and this warning was based on its interim data.
Q:What's the procedure of filing a lawsuit for Bladder cancer Actos?
A:In order to file a bladder cancer lawsuit, you can browse our page for basic information. You can also request for detailed information by filling out a quick form available on the website for free legal consultation. It is advisable that you contact a lawyer who has experience of Actos cases, to get the best results.